Company Filing History:
2 out of 9 
2 out of 24 
1 out of 188 
Years Active: 2000-2021
Title: Antonio De Flora: Innovator in Health and Medicine
Introduction
Antonio De Flora is a prominent inventor based in Genoa, Italy. He has made significant contributions to the fields of health and medicine, holding a total of six patents. His innovative work focuses on improving dietary sugar utilization and developing antitumor agents.
Latest Patents
One of his latest patents is a treatment for improving the use of dietary sugar for energy purposes. This invention involves the use of a very low dosage form of abscisic acid (ABA) or an in vivo hydrolysable conjugate thereof, preferably ABA-glucosyl ester (ABA-GE). It aims to control and prevent hyperglycemia and weight gain in response to sugar intake while reducing insulin secretion and increasing muscle performance.
Another notable patent is related to adenyl dinucleotides with antitumor activity. This invention introduces novel adenyl dinucleotides that are isomers of the dinucleotide Ap2A. These dinucleotides exhibit antitumor activity, particularly against hematological tumors such as leukemias and lymphomas. The invention also includes an enzymatic method for preparing these dinucleotides and an enzymatic assay method for one of the dinucleotides.
Career Highlights
Antonio De Flora has worked with several reputable organizations throughout his career. He has been associated with Biosearch Italia S.p.a., where he contributed to various research initiatives. Additionally, he has been involved with the Università Degli Studi Di Genova, furthering his impact in the academic and research community.
Collaborations
Throughout his career, Antonio has collaborated with notable individuals such as Umberto Benatti and Elena Zocchi. These collaborations have enriched his research and contributed to the advancement of his inventions.
Conclusion
Antonio De Flora is a distinguished inventor whose work in health and medicine has led to significant advancements. His innovative patents reflect his commitment to improving human health and addressing critical medical challenges.